KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Account Payables: 2015-2025

Historic Change in Account Payables for BeOne Medicines (ONC) over the last 11 years, with Sep 2025 value amounting to $28.5 million.

  • BeOne Medicines' Change in Account Payables rose 150.98% to $28.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.6 million, marking a year-over-year increase of 2652.60%. This contributed to the annual value of $121.5 million for FY2024, which is 465.52% up from last year.
  • As of Q3 2025, BeOne Medicines' Change in Account Payables stood at $28.5 million, which was up 764.59% from -$4.3 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Change in Account Payables registered a high of $108.0 million during Q4 2024, and its lowest value of -$73.2 million during Q1 2021.
  • In the last 3 years, BeOne Medicines' Change in Account Payables had a median value of -$4.3 million in 2025 and averaged $12.3 million.
  • Examining YoY changes over the last 5 years, BeOne Medicines' Change in Account Payables showed a top increase of 1,192.50% in 2024 and a maximum decrease of 337.19% in 2024.
  • Quarterly analysis of 5 years shows BeOne Medicines' Change in Account Payables stood at $32.4 million in 2021, then plummeted by 126.42% to -$8.6 million in 2022, then dropped by 15.51% to -$9.9 million in 2023, then spiked by 1,192.50% to $108.0 million in 2024, then soared by 150.98% to $28.5 million in 2025.
  • Its last three reported values are $28.5 million in Q3 2025, -$4.3 million for Q2 2025, and -$31.6 million during Q1 2025.